Refresh, Revitalize, and Rejuvenate
301.570.0030 (MD)
202.965.7546 (DC)

Juvederm Volbella Lip Filler Coming in October


JUVÉDERM VOLBELLA® XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids


 

JUVÉDERM VOLBELLA® XC found to increase lip fullness and soften the appearance of lines around the mouth through one year.

DUBLIN, June 1, 2016 /PRNewswire/ — Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA® XC, for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as perioral lines, in adults over the age of 21.1 In clinical trials, JUVÉDERM VOLBELLA® XC was found to effectively increase lip fullness and soften the appearance of lines around the mouth in a majority of subjects through one year.1,2*
 
“Many of my patients are very bothered by the lines that can appear around the lips, known as perioral rhytids. Additionally, when seeking lip augmentation, patients want a smooth, result that is not drastic” said Dr. David E. Bank, clinical trial investigator and founder of The Center for Dermatology, Cosmetic & Laser Surgery. “JUVÉDERM VOLBELLA® XC adds fullness to the lips and softens the appearance of the lines around the lips.2 With JUVÉDERM VOLBELLA® XC I am able to subtly enhance my patients’ pout.”
 
“The FDA approval of JUVÉDERM VOLBELLA® XC further demonstrates Allergan’s commitment to developing advanced products and technologies that allow healthcare providers to better address evolving patient needs,” said Bill Meury, Chief Commercial Officer, Allergan.
 
“Additionally, this approval brings to market a product unlike anything that is currently available in the United States. JUVÉDERM VOLBELLA® XC is formulated with VYCROSS®,2 a proprietary filler technology from Allergan, which yields smooth products that have been engineered to address specific patient concerns such as lip fullness, age-related volume loss in the cheek area, or perioral rhytids.3”
 
VYCROSS® blends different molecular weights of hyaluronic acid which contributes to the gel’s duration.1,3 In addition, JUVÉDERM VOLBELLA® XC has been customized with a lower HA concentration (15 mg/mL), while still providing the long-lasting results healthcare providers expect from the JUVÉDERM® collection of fillers.1,4,5,6,7,8 This makes JUVÉDERM VOLBELLA® XC a soft, smooth gel appropriate for adding subtle volume to the lips and softening the appearance of perioral lines.1
 
Allergan first debuted this innovative VYCROSS® technology in the U.S. in 2013 with the FDA approval of JUVÉDERM VOLUMA® XC for age-related mid-face volume loss.4 Now JUVÉDERM VOLBELLA® XC is the latest addition to the JUVÉDERM® collection of fillers, the number one selling collection of dermal filler products in the world,9 to receive FDA approval.
 
The safety and effectiveness of JUVÉDERM VOLBELLA® XC has been demonstrated in several clinical trials including the U.S. pivotal study where 168 subjects were treated with JUVÉDERM VOLBELLA® XC. A 5-point scale was used to evaluate the effectiveness of the product for lip fullness and a 4-point scale to evaluate the effectiveness of the product for smoothing lines around the mouth.2
 
Approximately two-thirds of subjects treated with VOLBELLA XC showed improvement in lip fullness and perioral lines through 1 year. The safety of JUVÉDERM VOLBELLA® XC was observed to be similar to that of the control. The most common side effects were temporary responses at the treatment site such as swelling, tenderness, bruising, firmness lumps/bumps, rednesss, pain, discoloration, and itching. Most of these side effects resolved within 30 days.2
 
JUVÉDERM VOLBELLA® XC was first approved in Europe in 2011. Currently, JUVÉDERM VOLBELLA® XC is distributed in more than 70 countries, including markets in Europe, Latin America, Middle East, Asia Pacific, and Canada. The JUVÉDERM® family of products, including JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC are marketed and sold in more than 80 countries outside the United States.10
 
JUVÉDERM VOLBELLA® XC will be available to patients in October 2016. For more information about JUVÉDERM VOLBELLA® XC and the JUVÉDERM® collection of fillers or to find a doctor, please visit www.juvederm.com.


contact us


Want More Information?

Call Us!

301 - 570 - 0030 (MD)

202 - 965 - 7546 (DC)

or

Fill Out The Form Below

  
  • Contact Us

    Your Name (required)

    Your Email (required)

    Subject

    (Please Specify Office Location)

    Your Message

    captcha

  • Like Us on Facebook

  • Recent Posts

  • testimonials


    I love coming to CSI. The staff is amazing and they make me feel so relaxed... Read more


    My entire family have been patients of Gloria Perez, their Medical Esthetician, for years... Read more


    The office is clean, bright and you feel very comfortable whether you are there for a facial, botox, fillers, laser treatments, or a make-up lesson. Susanne and Jessica are my “go to ” people... Read more


    I have been going to the Cosmetic Skin Institute for a couple of years. I could not be happier... Read more

    news


    Collagen P.I.N. Microneedling

    The Collagen P.I.N. microneedling treatment triggers new collagen synthesis, yet does not pose the risk of permanent scarring. The result is smoother, firmer and younger-looking skin......

    Read more
    Introducing Kybella

    KYBELLA® is the first FDA approved non-surgical injection for improving the appearance of moderate to severe submental fullness, commonly referred to as double chin.....

    Read more
    Introducing Restylane Lyft

    Restylane Lyft is the first and only FDA-approved filler indicated to provide fullness to cheeks and add volume to correct and smooth smile lines (nasolabial folds).....

    Read more

    our locations


    Cosmetic Skin Institute

    CSI Olney
    18111 Prince Philip Drive Suite 120
    Olney, MD 20832
    Phone: (301)570-0030

    CSI DC
    4400 MacArthur Blvd NW Suite 102A
    Washington, DC 20007
    Phone: (202)965-7546

    Jessica Lee
    (510)754-4951

    Judy Silvero
    (301)213-6131
    Copyright 2016 Cosmetic Skin Institute